Equities

Centro Escolar University

CEU:PHS

Centro Escolar University

Actions
Consumer DiscretionaryConsumer Services
  • Price (PHP)13.00
  • Today's Change-0.40 / -2.99%
  • Shares traded17.60k
  • 1 Year change+62.91%
  • Beta0.0017
Data delayed at least 15 minutes, as of Jul 26 2024 07:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Centro Escolar University is a Philippines-based institution of higher learning. The Company is engaged in maintaining and operating an educational institution or institutions for the instruction and training of the youth in all branches of the arts and sciences, offering classes in tertiary level. The Company operates in three geographic segments: Manila, Malolos and Makati. The Company, through Centro Escolar University Hospital, Inc. (the Hospital), establishes, maintains, and operates a hospital, medical and clinical laboratories and such other facilities that shall provide healthcare or any method of treatment for illnesses or abnormal physical or mental health in accordance with advancements in modern medicine and to provide education and training facilities in the furtherance of the health-related professions. Its academics include Undergraduate Programs, Graduate Programs, School of Medicine, Senior High School Program, and School of Law and Jurisprudence.

  • Revenue in PHP (TTM)2.06bn
  • Net income in PHP620.07m
  • Incorporated--
  • Employees1.16k
  • Location
    Centro Escolar University9 Mendiola St., San MiguelMANILA 1005PhilippinesPHL
  • Phone+63 27356861
  • Fax+63 27355991
  • Websitehttps://www.ceu.edu.ph/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.